BCVA can remain deceptively stable until late RP and becomes insensitive at profound vision loss, motivating ...
Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to ...
A Johnson & Johnson gene therapy in development for an inherited vision-loss disorder has failed a Phase 3 study, the latest clinical research setback for a rare eye disease that so far has no ...
Blinding diseases lead to permanent vision loss by damaging photoreceptor cells, which humans cannot naturally regenerate. While researchers are working on new methods to replace or regenerate these ...
Many retinal diseases begin long before patients experience noticeable vision loss.Clinicians frequently manage patients with ...
A UC Davis pilot study is exploring whether virtual reality eye exams can detect early signs of cognitive decline before ...
Please provide your email address to receive an email when new articles are posted on . AI apps and glasses had varying effectiveness in 14 daily living tasks but were well received by participants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results